Prediction Market Suggests SpaceX OpenAI and Anthropic Could Command FirstDay Valuations Above 14 Trillion Kraken Introduces Bitcoin Vault with Yield Generation for Investors Morocco Eyes Tourism Growth in Western Sahara Amid Sovereignty Dispute Indian Market Ends Week on Positive Note LowPriced Stocks Draw Attention Bain CapitalBacked Dhoot Transmission Files Updated DRHP for 1400 Crore IPO with Sebi Workday WDAY Attracts Analyst Attention as a Potentially Undervalued AI Play ONBPP Q1 2026 Earnings Slight EPS Miss Sends Shares Marginally Higher SRTS Q1 2026 Earnings EPS Falls Short of Estimates as Revenue Remains Undisclosed NIXX Q3 2023 Earnings EPS Surprises to the Upside Amid Revenue Disclosures Seer Inc Q1 2026 Earnings Narrower Loss Per Share Leads to Modest Stock Gain Anavex Life Sciences Corp AVXL Q1 2026 Earnings NarrowerThanExpected Loss Amid PreRevenue Pipeline Progress Ferrovial Q4 2025 Earnings EPS Beats Estimates Amidst Limited Revenue Disclosure Northwest Natural Holding NWN Edges Higher as Utility Sector Holds Steady Nu Skin Enterprises NUS Rebounds 37 as It Tests Key Resistance Zone Brunswick Corporation BC Rallies 298 as Marine Sector Shows Renewed Strength Northwest Natural Holding NWN Declines 167 Weighing Key Support Levels NETCLASS TECHNOLOGY INC NTCL Faces Renewed Selling Pressure Testing Key Support at 025 Endurance Technologies IPO Opens Key Details and Market Context CSR Q1 2026 Earnings Widely Misses EPS Estimates Stock Declines Park Ha Biological Technology BYAH Holds Gains as Stock Tests Key Support Zone PTCT Q1 2026 Earnings Narrower Loss Surprises Estimates as Stock Dips Slightly SUPV Q1 2026 Earnings Stunning EPS Beat of 270 Amid Operational Turnaround GRRR Q4 2025 Earnings Significant EPS Miss Despite Positive Stock Reaction Gerdau SA GGB Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly Keysight Technologies Q1 2026 Earnings Strong EPS Beat of 212 Amid Revenue Uncertainty CBZ Q1 2026 Earnings EPS Surpasses Estimates by 124 Shares Edge Higher Sagimet Biosciences Inc Q1 2026 Earnings Narrowed Loss Beats Expectations as Clinical Pipeline Advances